Cofounder, AdTheorent
Search every verified Josh Walsh interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Josh Walsh, co-founder and CEO of BranchLab, discussed the company's work in pharmaceutical advertising and its recent funding from Lance Armstrong's Next Ventures. On the Open Market podcast, Walsh described receiving an unsolicited LinkedIn message from Armstrong, which led to a meeting and a deal closing within the week. He also spoke about BranchLab's focus on consumer brands and the distinct responsibilities of pharma advertisers, noting that the industry's commercialization and measurement processes have historically been manual and slow. In a separate appearance on the Architecture Podcast, Walsh discussed BranchLab's use of neural networks trained on non-health data to address privacy concerns and enable audience insights. He predicted that an outright ban on pharmaceutical TV advertising is unlikely, citing First Amendment protections, while expressing support for potential regulation and emphasizing that responsibly produced advertising can improve public health outcomes by increasing doctor visits. Walsh also commented on the broader industry, stating that pharma advertising has lagged due to challenging data assets and complex regulations.
Josh Walsh, Co-Founder & CEO of BranchLab, joins Eric and Joe to discuss transforming pharma advertising with AI, scaling a second startup, and an unexpectedly important LinkedIn message from Lance Armstrong.
Ari Paparo and Eric Franchi speak with Josh Walsh, founder and CEO of BranchLab, about how pharmaceutical advertising is changing. The discussion covers BranchLab’s use of neural networks with non-health data, the impact of new privacy regulations, and recent funding from Lance Armstrong’s Next Ventures. The conversation also touches on Deep Intent’s acquisition, ongoing federal policy debates, and the broader implications for healthcare marketing. Takeaways BranchLab’s Model: Neural networks trained on non-health data can help address privacy concerns while enabling audience insights. Fundin…
Sign in to search the full transcript archive, filter by topic, and access every quote from Josh Walsh.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans